Skip to main content

Table 1 A brief study schedule at every visit.

From: A placebo-controlled trial of Korean red ginseng extract for preventing Influenza-like illness in healthy adults

  Screening
Visit 1
Baseline
Visit 2
Visit 3 Visit 4 Visit 5 Follow up
(Visit 6)
  D-21
~D-1
Week 0
D0
Week 4
D28
Week 8
D56
Week 12
D84
Week 17
D119
Informed consent form      
Demographic information taking 1      
Medical history taking  
Inclusion/exclusion criteria check     
Physician examination 2      
Vital sign measurement  
Concomitant drugs check  
Electrocardiogram(ECG)      
Questionnaires for symptoms related to ILI 3
Laboratory test 4      
Study product distribution     
Compliance checking     
Adverse event monitoring   
  1. : Item need to be performed during the visit
  2. 1 Sex, date of birth, age, contact address and phone number
  3. 2 Include present illness, past history taking
  4. 3 Frequency of ILI symptom onset, severity of ILI symptoms, and duration of ILI symptoms
  5. 4 Blood test (WBC, RBC, hemoglobin, hematocrit, platelets count, AST, ALT, ALP, gamma-GTP, albumin, BUN, creatinine, glucose, total bilirubin, total protein), urine test (specific gravity, pH, protein, ketone, glucose, bilirubin, urobilinogen, nitrite, microscopic (RBC, WBC))